Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Clinical Education Environment Assessment Scale

10 de julio de 2026 actualizado por: Demet Öztürk, Lokman Hekim University

Development and Psychometric Evaluation of the Clinical Education Environment Assessment Scale for Health Sciences Students

This study aims to develop and evaluate a questionnaire that measures how health sciences students perceive the clinical environments in which they complete internships or clinical placements. The questionnaire will assess areas such as patient characteristics, supervisor support, working conditions, physical facilities, and learning experiences.

Fourth-year health sciences students who have previously completed clinical training will be invited to complete an anonymous questionnaire. Participation is voluntary, and completing the questionnaire will take approximately 10 minutes. No intervention, treatment, image recording, or biological sample collection will be involved.

The results may help universities and clinical training institutions identify strengths and areas for improvement in clinical education environments. The developed scale may also support educational quality assurance and accreditation processes.

Descripción general del estudio

Estado

Aún no reclutando

Intervención / Tratamiento

Descripción detallada

This cross-sectional scale development study aims to develop and evaluate the psychometric properties of the Clinical Education Environment Assessment Scale for Health Sciences Students. The scale is intended to assess students' perceptions of the quality and suitability of the clinical environments in which they complete internships and clinical placements.

Clinical education is an essential component of health sciences education because it enables students to apply theoretical knowledge, develop practical skills, improve clinical decision-making, and gain experience within healthcare teams. Students' learning outcomes and satisfaction may be influenced by several features of the clinical environment, including patient diversity, supervision quality, working conditions, physical facilities, access to equipment, opportunities for active participation, and overall learning experiences. However, existing clinical learning environment instruments are generally developed for specific disciplines and may not fully reflect the needs of students from different health sciences programs.

The study will include fourth-year undergraduate students from health sciences programs who have previously participated in clinical practice or internship training. Students who have not completed clinical placements or who provide incomplete questionnaires will be excluded. Participants will be recruited from Hacettepe University Faculty of Physical Therapy and Rehabilitation and Lokman Hekim University Faculty of Health Sciences using convenience sampling.

The proposed scale is expected to include approximately 31 items covering patient characteristics, supervisor characteristics, working conditions, physical environment and infrastructure, and learning experience. Participants will also provide limited demographic information, including age, sex, department, and clinical placement participation status. Completing the questionnaire is expected to take approximately 10 minutes.

The scale development process will include content validity, construct validity, and reliability analyses. Content validity will be assessed through expert review involving academics from relevant health sciences disciplines. Exploratory and confirmatory factor analyses will be conducted to evaluate the factor structure of the scale. Internal consistency will be assessed using Cronbach's alpha coefficients and corrected item-total correlations.

Participation will be voluntary and anonymous. No intervention, biological sample collection, image recording, or audio recording will be performed. The findings may contribute to the evaluation and improvement of clinical education environments, support student-centered quality assurance processes, and provide a standardized tool for use in health sciences education and accreditation activities.

Tipo de estudio

De observación

Inscripción (Estimado)

310

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Ankara
      • Ankara, Ankara, Turquía (Türkiye), 06370
        • Lokman Hekim University, Ankara, Ankara
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

The study population will consist of fourth-year undergraduate students enrolled in health sciences programs at Hacettepe University Faculty of Physical Therapy and Rehabilitation and Lokman Hekim University Faculty of Health Sciences. Eligible students will be those who have previously completed or are currently participating in clinical practice, internship, or clinical placement training.

Students from Physiotherapy and Rehabilitation, Nutrition and Dietetics, Speech and Language Therapy, Midwifery, Occupational Therapy, Nursing, and Audiology programs may be included. Participants will be recruited using convenience sampling through relevant academic staff, clinical education settings, and student representatives.

A minimum sample of 310 students is planned, based on the anticipated 31-item scale and the recommendation to recruit at least 10 participants per item for scale development studies. Participation will be voluntary, and all data will be collected anonymously through sel

Descripción

Inclusion Criteria:

  • Fourth-year undergraduate student enrolled in a health sciences program.
  • Previous or current experience of clinical practice, internship, or clinical placement.
  • Able to read and understand Turkish.
  • Provides voluntary informed consent to participate.

Exclusion Criteria:

  • No previous or current clinical practice, internship, or clinical placement experience.
  • Incomplete questionnaire responses.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Health Sciences Students with Clinical Placement Experience
Fourth-year undergraduate students enrolled in health sciences programs who have previously completed or are currently completing clinical practice, internship, or clinical placement training. Participants will complete an anonymous questionnaire evaluating their clinical education environment.
Participants completed assessment forms. No intervention was administered.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Exploratory Factor Analysis Factor Loadings
Periodo de tiempo: Baseline (Day 1)
The factor structure of the newly developed scale will be evaluated using exploratory factor analysis. Factor loadings of the scale items will be examined to determine the contribution of each item to the underlying factor structure. Higher factor loadings indicate stronger association between the item and the relevant factor.
Baseline (Day 1)
Explained Variance in Exploratory Factor Analysis
Periodo de tiempo: Baseline day 1
The total variance explained by the factor structure identified through exploratory factor analysis will be calculated. A higher percentage of explained variance indicates that the factor structure accounts for a greater proportion of the variability in scale responses.
Baseline day 1
Kaiser-Meyer-Olkin Measure of Sampling Adequacy
Periodo de tiempo: Baseline (day 1)
The adequacy of the data for factor analysis will be assessed using the Kaiser-Meyer-Olkin measure. Higher values indicate greater suitability of the data for factor analysis.
Baseline (day 1)
Bartlett's Test of Sphericity
Periodo de tiempo: Baseline (day 1)
The suitability of the correlation matrix for factor analysis will be assessed using Bartlett's test of sphericity. A statistically significant result indicates that the correlation matrix is appropriate for factor analysis.
Baseline (day 1)
Confirmatory Factor Analysis Model Fit Indices
Periodo de tiempo: Baseline (day 1)
Confirmatory factor analysis will be used to evaluate the fit of the proposed factor structure. Model fit will be assessed using standard fit indices, including chi-square/degrees of freedom, CFI, NFI, NNFI, IFI, SRMR, and RMSEA. Better model fit indices indicate greater support for the proposed factor structure.
Baseline (day 1)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de agosto de 2026

Finalización primaria (Estimado)

1 de septiembre de 2026

Finalización del estudio (Estimado)

1 de enero de 2027

Fechas de registro del estudio

Enviado por primera vez

1 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de julio de 2026

Publicado por primera vez (Actual)

16 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2026-XXÖ

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir